nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—DRD2—nicotine dependence	0.628	1	CbGaD
Mirtazapine—Restless legs syndrome—Varenicline—nicotine dependence	0.00673	0.0345	CcSEcCtD
Mirtazapine—Withdrawal symptom—Varenicline—nicotine dependence	0.00468	0.024	CcSEcCtD
Mirtazapine—Aphthous stomatitis—Varenicline—nicotine dependence	0.0041	0.021	CcSEcCtD
Mirtazapine—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00392	0.0201	CcSEcCtD
Mirtazapine—Myositis—Varenicline—nicotine dependence	0.00392	0.0201	CcSEcCtD
Mirtazapine—Hostility—Varenicline—nicotine dependence	0.00347	0.0178	CcSEcCtD
Mirtazapine—Vaginal discharge—Varenicline—nicotine dependence	0.00316	0.0162	CcSEcCtD
Mirtazapine—Libido increased—Varenicline—nicotine dependence	0.00316	0.0162	CcSEcCtD
Mirtazapine—Parosmia—Varenicline—nicotine dependence	0.00296	0.0152	CcSEcCtD
Mirtazapine—Paranoia—Varenicline—nicotine dependence	0.00282	0.0145	CcSEcCtD
Mirtazapine—Intestinal obstruction—Varenicline—nicotine dependence	0.00282	0.0145	CcSEcCtD
Mirtazapine—Suicidal ideation—Varenicline—nicotine dependence	0.00274	0.0141	CcSEcCtD
Mirtazapine—Delusion—Varenicline—nicotine dependence	0.00272	0.0139	CcSEcCtD
Mirtazapine—Nystagmus—Varenicline—nicotine dependence	0.00269	0.0138	CcSEcCtD
Mirtazapine—Hyperlipidaemia—Varenicline—nicotine dependence	0.00267	0.0137	CcSEcCtD
Mirtazapine—Mania—Varenicline—nicotine dependence	0.00264	0.0136	CcSEcCtD
Mirtazapine—Menorrhagia—Varenicline—nicotine dependence	0.0026	0.0133	CcSEcCtD
Mirtazapine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00255	0.0131	CcSEcCtD
Mirtazapine—Nephrolithiasis—Varenicline—nicotine dependence	0.00239	0.0123	CcSEcCtD
Mirtazapine—Acne—Varenicline—nicotine dependence	0.00228	0.0117	CcSEcCtD
Mirtazapine—Disturbance in attention—Varenicline—nicotine dependence	0.00222	0.0114	CcSEcCtD
Mirtazapine—Aggression—Varenicline—nicotine dependence	0.00219	0.0112	CcSEcCtD
Mirtazapine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00213	0.0109	CcSEcCtD
Mirtazapine—Thinking abnormal—Varenicline—nicotine dependence	0.0021	0.0108	CcSEcCtD
Mirtazapine—Dysarthria—Varenicline—nicotine dependence	0.00203	0.0104	CcSEcCtD
Mirtazapine—Coordination abnormal—Varenicline—nicotine dependence	0.00196	0.01	CcSEcCtD
Mirtazapine—Pulmonary embolism—Varenicline—nicotine dependence	0.00192	0.00987	CcSEcCtD
Mirtazapine—Abnormal dreams—Varenicline—nicotine dependence	0.0019	0.00975	CcSEcCtD
Mirtazapine—Eructation—Varenicline—nicotine dependence	0.00189	0.00969	CcSEcCtD
Mirtazapine—Salivary hypersecretion—Varenicline—nicotine dependence	0.00187	0.00958	CcSEcCtD
Mirtazapine—Nightmare—Varenicline—nicotine dependence	0.00186	0.00953	CcSEcCtD
Mirtazapine—HRH3—brain—nicotine dependence	0.00184	0.0578	CbGeAlD
Mirtazapine—DRD4—brain—nicotine dependence	0.00181	0.057	CbGeAlD
Mirtazapine—Urine output increased—Varenicline—nicotine dependence	0.00174	0.00892	CcSEcCtD
Mirtazapine—Mouth ulceration—Varenicline—nicotine dependence	0.00174	0.00892	CcSEcCtD
Mirtazapine—Hypertonia—Varenicline—nicotine dependence	0.00168	0.00865	CcSEcCtD
Mirtazapine—Mental disability—Varenicline—nicotine dependence	0.00167	0.00856	CcSEcCtD
Mirtazapine—Euphoric mood—Varenicline—nicotine dependence	0.00165	0.00848	CcSEcCtD
Mirtazapine—Lymphadenopathy—Varenicline—nicotine dependence	0.00164	0.00839	CcSEcCtD
Mirtazapine—Diabetes mellitus—Varenicline—nicotine dependence	0.0016	0.00823	CcSEcCtD
Mirtazapine—Polyuria—Varenicline—nicotine dependence	0.00159	0.00816	CcSEcCtD
Mirtazapine—Disorientation—Varenicline—nicotine dependence	0.00156	0.00801	CcSEcCtD
Mirtazapine—Deafness—Varenicline—nicotine dependence	0.00156	0.00801	CcSEcCtD
Mirtazapine—Eye pain—Varenicline—nicotine dependence	0.00155	0.00793	CcSEcCtD
Mirtazapine—Libido decreased—Varenicline—nicotine dependence	0.0015	0.00772	CcSEcCtD
Mirtazapine—Increased appetite—Varenicline—nicotine dependence	0.00149	0.00762	CcSEcCtD
Mirtazapine—Amnesia—Varenicline—nicotine dependence	0.00149	0.00762	CcSEcCtD
Mirtazapine—Thirst—Varenicline—nicotine dependence	0.00147	0.00753	CcSEcCtD
Mirtazapine—Arthritis—Varenicline—nicotine dependence	0.00144	0.00737	CcSEcCtD
Mirtazapine—Lethargy—Varenicline—nicotine dependence	0.00142	0.00731	CcSEcCtD
Mirtazapine—ADRB1—cardiovascular system—nicotine dependence	0.00142	0.0445	CbGeAlD
Mirtazapine—Osteoarthritis—Varenicline—nicotine dependence	0.0014	0.00716	CcSEcCtD
Mirtazapine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00138	0.0071	CcSEcCtD
Mirtazapine—Migraine—Varenicline—nicotine dependence	0.00137	0.00705	CcSEcCtD
Mirtazapine—Affect lability—Varenicline—nicotine dependence	0.00137	0.00705	CcSEcCtD
Mirtazapine—Psychotic disorder—Varenicline—nicotine dependence	0.00136	0.00699	CcSEcCtD
Mirtazapine—HTR2B—cardiovascular system—nicotine dependence	0.00136	0.0426	CbGeAlD
Mirtazapine—Urinary retention—Varenicline—nicotine dependence	0.00133	0.00681	CcSEcCtD
Mirtazapine—Mood swings—Varenicline—nicotine dependence	0.00132	0.00678	CcSEcCtD
Mirtazapine—Liver function test abnormal—Varenicline—nicotine dependence	0.00129	0.00661	CcSEcCtD
Mirtazapine—Dry skin—Varenicline—nicotine dependence	0.00128	0.00656	CcSEcCtD
Mirtazapine—DRD3—brain—nicotine dependence	0.00127	0.04	CbGeAlD
Mirtazapine—Gastritis—Varenicline—nicotine dependence	0.00123	0.00634	CcSEcCtD
Mirtazapine—HTR1A—cardiovascular system—nicotine dependence	0.00121	0.0382	CbGeAlD
Mirtazapine—Abdominal distension—Varenicline—nicotine dependence	0.00121	0.00623	CcSEcCtD
Mirtazapine—Asthma—Varenicline—nicotine dependence	0.00121	0.00619	CcSEcCtD
Mirtazapine—Angina pectoris—Varenicline—nicotine dependence	0.00117	0.00603	CcSEcCtD
Mirtazapine—SLC6A3—midbrain—nicotine dependence	0.00117	0.0367	CbGeAlD
Mirtazapine—HTR7—cardiovascular system—nicotine dependence	0.00116	0.0365	CbGeAlD
Mirtazapine—Bronchitis—Varenicline—nicotine dependence	0.00116	0.00595	CcSEcCtD
Mirtazapine—OPRK1—brain—nicotine dependence	0.00113	0.0357	CbGeAlD
Mirtazapine—HTR2C—midbrain—nicotine dependence	0.00113	0.0354	CbGeAlD
Mirtazapine—ADRA1A—cardiovascular system—nicotine dependence	0.00112	0.0352	CbGeAlD
Mirtazapine—Pollakiuria—Varenicline—nicotine dependence	0.00111	0.00572	CcSEcCtD
Mirtazapine—Erectile dysfunction—Varenicline—nicotine dependence	0.00111	0.0057	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Varenicline—nicotine dependence	0.0011	0.00565	CcSEcCtD
Mirtazapine—Weight increased—Varenicline—nicotine dependence	0.0011	0.00563	CcSEcCtD
Mirtazapine—SLC6A4—midbrain—nicotine dependence	0.00107	0.0336	CbGeAlD
Mirtazapine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00107	0.00547	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00106	0.00544	CcSEcCtD
Mirtazapine—Myocardial infarction—Varenicline—nicotine dependence	0.00105	0.00541	CcSEcCtD
Mirtazapine—Stomatitis—Varenicline—nicotine dependence	0.00105	0.00538	CcSEcCtD
Mirtazapine—Conjunctivitis—Varenicline—nicotine dependence	0.00105	0.00536	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00102	0.00522	CcSEcCtD
Mirtazapine—Epistaxis—Varenicline—nicotine dependence	0.00101	0.00521	CcSEcCtD
Mirtazapine—Sinusitis—Varenicline—nicotine dependence	0.00101	0.00518	CcSEcCtD
Mirtazapine—Bradycardia—Varenicline—nicotine dependence	0.000983	0.00504	CcSEcCtD
Mirtazapine—Hallucination—Varenicline—nicotine dependence	0.00096	0.00493	CcSEcCtD
Mirtazapine—Hypoaesthesia—Varenicline—nicotine dependence	0.00096	0.00493	CcSEcCtD
Mirtazapine—Urinary tract disorder—Varenicline—nicotine dependence	0.000953	0.00489	CcSEcCtD
Mirtazapine—Oedema peripheral—Varenicline—nicotine dependence	0.000951	0.00488	CcSEcCtD
Mirtazapine—HTR1A—midbrain—nicotine dependence	0.000948	0.0298	CbGeAlD
Mirtazapine—Urethral disorder—Varenicline—nicotine dependence	0.000946	0.00486	CcSEcCtD
Mirtazapine—Erythema multiforme—Varenicline—nicotine dependence	0.000913	0.00468	CcSEcCtD
Mirtazapine—HTR7—midbrain—nicotine dependence	0.000906	0.0285	CbGeAlD
Mirtazapine—Eye disorder—Varenicline—nicotine dependence	0.000902	0.00463	CcSEcCtD
Mirtazapine—Tinnitus—Varenicline—nicotine dependence	0.0009	0.00462	CcSEcCtD
Mirtazapine—Cardiac disorder—Varenicline—nicotine dependence	0.000896	0.0046	CcSEcCtD
Mirtazapine—HTR3A—brain—nicotine dependence	0.00088	0.0277	CbGeAlD
Mirtazapine—CYP2C9—cardiovascular system—nicotine dependence	0.000879	0.0276	CbGeAlD
Mirtazapine—Angiopathy—Varenicline—nicotine dependence	0.000876	0.00449	CcSEcCtD
Mirtazapine—Chills—Varenicline—nicotine dependence	0.000866	0.00445	CcSEcCtD
Mirtazapine—Arrhythmia—Varenicline—nicotine dependence	0.000862	0.00443	CcSEcCtD
Mirtazapine—DRD2—midbrain—nicotine dependence	0.000857	0.027	CbGeAlD
Mirtazapine—Mental disorder—Varenicline—nicotine dependence	0.000846	0.00434	CcSEcCtD
Mirtazapine—Malnutrition—Varenicline—nicotine dependence	0.00084	0.00431	CcSEcCtD
Mirtazapine—ADRA2C—midbrain—nicotine dependence	0.000833	0.0262	CbGeAlD
Mirtazapine—Flatulence—Varenicline—nicotine dependence	0.000828	0.00425	CcSEcCtD
Mirtazapine—Dysgeusia—Varenicline—nicotine dependence	0.000823	0.00422	CcSEcCtD
Mirtazapine—Back pain—Varenicline—nicotine dependence	0.000813	0.00417	CcSEcCtD
Mirtazapine—Tremor—Varenicline—nicotine dependence	0.000787	0.00404	CcSEcCtD
Mirtazapine—Ill-defined disorder—Varenicline—nicotine dependence	0.00078	0.004	CcSEcCtD
Mirtazapine—Anaemia—Varenicline—nicotine dependence	0.000777	0.00399	CcSEcCtD
Mirtazapine—Agitation—Varenicline—nicotine dependence	0.000772	0.00396	CcSEcCtD
Mirtazapine—Malaise—Varenicline—nicotine dependence	0.000758	0.00389	CcSEcCtD
Mirtazapine—Vertigo—Varenicline—nicotine dependence	0.000755	0.00387	CcSEcCtD
Mirtazapine—Syncope—Varenicline—nicotine dependence	0.000754	0.00387	CcSEcCtD
Mirtazapine—Palpitations—Varenicline—nicotine dependence	0.000743	0.00381	CcSEcCtD
Mirtazapine—Loss of consciousness—Varenicline—nicotine dependence	0.000738	0.00379	CcSEcCtD
Mirtazapine—Cough—Varenicline—nicotine dependence	0.000733	0.00376	CcSEcCtD
Mirtazapine—SLC6A3—brain—nicotine dependence	0.000732	0.023	CbGeAlD
Mirtazapine—Convulsion—Varenicline—nicotine dependence	0.000728	0.00374	CcSEcCtD
Mirtazapine—Hypertension—Varenicline—nicotine dependence	0.000725	0.00372	CcSEcCtD
Mirtazapine—HTR2A—cardiovascular system—nicotine dependence	0.000724	0.0228	CbGeAlD
Mirtazapine—Chest pain—Varenicline—nicotine dependence	0.000715	0.00367	CcSEcCtD
Mirtazapine—Myalgia—Varenicline—nicotine dependence	0.000715	0.00367	CcSEcCtD
Mirtazapine—Arthralgia—Varenicline—nicotine dependence	0.000715	0.00367	CcSEcCtD
Mirtazapine—Anxiety—Varenicline—nicotine dependence	0.000713	0.00366	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00071	0.00365	CcSEcCtD
Mirtazapine—HTR2C—brain—nicotine dependence	0.000708	0.0223	CbGeAlD
Mirtazapine—Discomfort—Varenicline—nicotine dependence	0.000707	0.00363	CcSEcCtD
Mirtazapine—Dry mouth—Varenicline—nicotine dependence	0.0007	0.00359	CcSEcCtD
Mirtazapine—ADRB1—brain—nicotine dependence	0.000695	0.0219	CbGeAlD
Mirtazapine—Oedema—Varenicline—nicotine dependence	0.000686	0.00352	CcSEcCtD
Mirtazapine—Infection—Varenicline—nicotine dependence	0.000681	0.0035	CcSEcCtD
Mirtazapine—Shock—Varenicline—nicotine dependence	0.000675	0.00346	CcSEcCtD
Mirtazapine—Nervous system disorder—Varenicline—nicotine dependence	0.000672	0.00345	CcSEcCtD
Mirtazapine—Thrombocytopenia—Varenicline—nicotine dependence	0.000671	0.00345	CcSEcCtD
Mirtazapine—SLC6A4—brain—nicotine dependence	0.000671	0.0211	CbGeAlD
Mirtazapine—Tachycardia—Varenicline—nicotine dependence	0.000669	0.00344	CcSEcCtD
Mirtazapine—Skin disorder—Varenicline—nicotine dependence	0.000666	0.00342	CcSEcCtD
Mirtazapine—HTR2B—brain—nicotine dependence	0.000665	0.0209	CbGeAlD
Mirtazapine—ADRA2A—midbrain—nicotine dependence	0.000665	0.0209	CbGeAlD
Mirtazapine—Hyperhidrosis—Varenicline—nicotine dependence	0.000663	0.0034	CcSEcCtD
Mirtazapine—Anorexia—Varenicline—nicotine dependence	0.000654	0.00336	CcSEcCtD
Mirtazapine—Hypotension—Varenicline—nicotine dependence	0.000641	0.00329	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000625	0.00321	CcSEcCtD
Mirtazapine—Insomnia—Varenicline—nicotine dependence	0.00062	0.00318	CcSEcCtD
Mirtazapine—Dyspnoea—Varenicline—nicotine dependence	0.000611	0.00314	CcSEcCtD
Mirtazapine—Somnolence—Varenicline—nicotine dependence	0.00061	0.00313	CcSEcCtD
Mirtazapine—Dyspepsia—Varenicline—nicotine dependence	0.000604	0.0031	CcSEcCtD
Mirtazapine—Decreased appetite—Varenicline—nicotine dependence	0.000596	0.00306	CcSEcCtD
Mirtazapine—HTR1A—brain—nicotine dependence	0.000596	0.0187	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000592	0.00304	CcSEcCtD
Mirtazapine—Fatigue—Varenicline—nicotine dependence	0.000591	0.00303	CcSEcCtD
Mirtazapine—SLC6A2—brain—nicotine dependence	0.000591	0.0186	CbGeAlD
Mirtazapine—Constipation—Varenicline—nicotine dependence	0.000586	0.00301	CcSEcCtD
Mirtazapine—Pain—Varenicline—nicotine dependence	0.000586	0.00301	CcSEcCtD
Mirtazapine—HTR7—brain—nicotine dependence	0.000569	0.0179	CbGeAlD
Mirtazapine—HTR2A—midbrain—nicotine dependence	0.000565	0.0178	CbGeAlD
Mirtazapine—Feeling abnormal—Varenicline—nicotine dependence	0.000565	0.0029	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Varenicline—nicotine dependence	0.000561	0.00288	CcSEcCtD
Mirtazapine—ADRA1A—brain—nicotine dependence	0.000549	0.0173	CbGeAlD
Mirtazapine—Urticaria—Varenicline—nicotine dependence	0.000545	0.0028	CcSEcCtD
Mirtazapine—Body temperature increased—Varenicline—nicotine dependence	0.000542	0.00278	CcSEcCtD
Mirtazapine—Abdominal pain—Varenicline—nicotine dependence	0.000542	0.00278	CcSEcCtD
Mirtazapine—DRD2—brain—nicotine dependence	0.000538	0.0169	CbGeAlD
Mirtazapine—ADRA2C—brain—nicotine dependence	0.000523	0.0165	CbGeAlD
Mirtazapine—Hypersensitivity—Varenicline—nicotine dependence	0.000505	0.00259	CcSEcCtD
Mirtazapine—Asthenia—Varenicline—nicotine dependence	0.000492	0.00253	CcSEcCtD
Mirtazapine—CYP2C8—brain—nicotine dependence	0.000485	0.0153	CbGeAlD
Mirtazapine—Pruritus—Varenicline—nicotine dependence	0.000485	0.00249	CcSEcCtD
Mirtazapine—Diarrhoea—Varenicline—nicotine dependence	0.000469	0.00241	CcSEcCtD
Mirtazapine—Dizziness—Varenicline—nicotine dependence	0.000453	0.00233	CcSEcCtD
Mirtazapine—Vomiting—Varenicline—nicotine dependence	0.000436	0.00224	CcSEcCtD
Mirtazapine—Rash—Varenicline—nicotine dependence	0.000432	0.00222	CcSEcCtD
Mirtazapine—Dermatitis—Varenicline—nicotine dependence	0.000432	0.00222	CcSEcCtD
Mirtazapine—Headache—Varenicline—nicotine dependence	0.00043	0.00221	CcSEcCtD
Mirtazapine—HRH1—brain—nicotine dependence	0.000425	0.0134	CbGeAlD
Mirtazapine—ADRA2A—brain—nicotine dependence	0.000418	0.0131	CbGeAlD
Mirtazapine—Nausea—Varenicline—nicotine dependence	0.000407	0.00209	CcSEcCtD
Mirtazapine—HTR2A—brain—nicotine dependence	0.000355	0.0112	CbGeAlD
Mirtazapine—CYP2D6—brain—nicotine dependence	0.000323	0.0102	CbGeAlD
Mirtazapine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000133	0.000916	CbGpPWpGaD
Mirtazapine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000133	0.000915	CbGpPWpGaD
Mirtazapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000131	0.000898	CbGpPWpGaD
Mirtazapine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00013	0.000896	CbGpPWpGaD
Mirtazapine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00013	0.000891	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000129	0.000889	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000129	0.000886	CbGpPWpGaD
Mirtazapine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000128	0.000881	CbGpPWpGaD
Mirtazapine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000128	0.000877	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.000126	0.00087	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000126	0.000867	CbGpPWpGaD
Mirtazapine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000126	0.000865	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000126	0.000864	CbGpPWpGaD
Mirtazapine—HRH3—GPCR downstream signaling—DRD2—nicotine dependence	0.000125	0.000862	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000124	0.000852	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000124	0.00085	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000124	0.00085	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000123	0.000848	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000123	0.000846	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000123	0.000845	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000121	0.000834	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000121	0.000832	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.00012	0.000827	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00012	0.000823	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000118	0.000808	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000117	0.000807	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000117	0.000804	CbGpPWpGaD
Mirtazapine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000117	0.000802	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000117	0.000801	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000116	0.000797	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.000115	0.00079	CbGpPWpGaD
Mirtazapine—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.000115	0.000789	CbGpPWpGaD
Mirtazapine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000114	0.000785	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000114	0.000784	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—DRD2—nicotine dependence	0.000114	0.000783	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000114	0.000782	CbGpPWpGaD
Mirtazapine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000113	0.000774	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000112	0.000773	CbGpPWpGaD
Mirtazapine—Mianserin—DRD2—nicotine dependence	0.000112	1	CrCbGaD
Mirtazapine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000112	0.000772	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000112	0.000772	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000112	0.000768	CbGpPWpGaD
Mirtazapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000112	0.000767	CbGpPWpGaD
Mirtazapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000111	0.000764	CbGpPWpGaD
Mirtazapine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00011	0.000759	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00011	0.000758	CbGpPWpGaD
Mirtazapine—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.00011	0.000755	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000109	0.000751	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000109	0.000747	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000109	0.000747	CbGpPWpGaD
Mirtazapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000108	0.000743	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—WASF2—nicotine dependence	0.000108	0.000741	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000107	0.000735	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000107	0.000733	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000105	0.000721	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000105	0.000719	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000717	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—WASF1—nicotine dependence	0.000103	0.00071	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000103	0.00071	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000102	0.000704	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000102	0.000698	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000101	0.000697	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	9.94e-05	0.000684	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	9.86e-05	0.000678	CbGpPWpGaD
Mirtazapine—DRD3—GPCR ligand binding—DRD2—nicotine dependence	9.75e-05	0.000671	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	9.72e-05	0.000668	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	9.7e-05	0.000667	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	9.7e-05	0.000667	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	9.68e-05	0.000666	CbGpPWpGaD
Mirtazapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.64e-05	0.000663	CbGpPWpGaD
Mirtazapine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.62e-05	0.000662	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	9.5e-05	0.000653	CbGpPWpGaD
Mirtazapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.44e-05	0.000649	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—OPRM1—nicotine dependence	9.3e-05	0.000639	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.24e-05	0.000635	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	9.11e-05	0.000626	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—FGD1—nicotine dependence	9.09e-05	0.000625	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	8.97e-05	0.000616	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—FGD1—nicotine dependence	8.95e-05	0.000616	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	8.89e-05	0.000611	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	8.84e-05	0.000608	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	8.83e-05	0.000607	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	8.77e-05	0.000603	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	8.69e-05	0.000598	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	8.65e-05	0.000595	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	8.58e-05	0.00059	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—FGD1—nicotine dependence	8.57e-05	0.000589	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.5e-05	0.000584	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.46e-05	0.000581	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.45e-05	0.000581	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.41e-05	0.000578	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	8.27e-05	0.000569	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.22e-05	0.000566	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.19e-05	0.000563	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.18e-05	0.000563	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.18e-05	0.000563	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	8.14e-05	0.00056	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	8.03e-05	0.000552	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	7.91e-05	0.000544	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	7.79e-05	0.000536	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	7.62e-05	0.000524	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—FGD1—nicotine dependence	7.61e-05	0.000523	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	7.57e-05	0.000521	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.44e-05	0.000512	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.42e-05	0.00051	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.34e-05	0.000505	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	7.33e-05	0.000504	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.3e-05	0.000502	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	7.29e-05	0.000501	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.23e-05	0.000497	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	7.19e-05	0.000494	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	7.15e-05	0.000492	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	6.95e-05	0.000478	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—FGD1—nicotine dependence	6.94e-05	0.000477	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	6.92e-05	0.000476	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	6.79e-05	0.000467	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—FGD1—nicotine dependence	6.78e-05	0.000467	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—DRD2—nicotine dependence	6.72e-05	0.000462	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	6.72e-05	0.000462	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	6.68e-05	0.000459	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	6.64e-05	0.000457	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.64e-05	0.000457	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.63e-05	0.000456	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.61e-05	0.000454	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.6e-05	0.000454	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	6.58e-05	0.000453	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	6.48e-05	0.000446	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.43e-05	0.000442	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.42e-05	0.000441	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	6.31e-05	0.000434	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.3e-05	0.000433	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.2e-05	0.000427	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	6.17e-05	0.000424	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	6.13e-05	0.000421	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.03e-05	0.000415	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6e-05	0.000413	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	5.99e-05	0.000412	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	5.98e-05	0.000411	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	5.92e-05	0.000407	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—DRD2—nicotine dependence	5.89e-05	0.000405	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	5.86e-05	0.000403	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	5.84e-05	0.000401	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	5.83e-05	0.000401	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	5.83e-05	0.000401	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—FGD1—nicotine dependence	5.82e-05	0.000401	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.74e-05	0.000395	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.73e-05	0.000394	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	5.73e-05	0.000394	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—FGD1—nicotine dependence	5.72e-05	0.000393	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	5.67e-05	0.00039	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—WASF2—nicotine dependence	5.66e-05	0.000389	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.63e-05	0.000387	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.62e-05	0.000386	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.61e-05	0.000386	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—WASF2—nicotine dependence	5.57e-05	0.000383	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.51e-05	0.000379	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—WASF1—nicotine dependence	5.43e-05	0.000373	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.38e-05	0.00037	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—WASF1—nicotine dependence	5.34e-05	0.000367	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.33e-05	0.000367	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.3e-05	0.000364	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.22e-05	0.000359	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.21e-05	0.000359	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.21e-05	0.000358	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	5.2e-05	0.000358	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.14e-05	0.000354	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.12e-05	0.000352	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.11e-05	0.000352	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.1e-05	0.000351	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.09e-05	0.00035	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.06e-05	0.000348	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	5.05e-05	0.000347	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	5.02e-05	0.000345	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5e-05	0.000344	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	4.96e-05	0.000341	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	4.91e-05	0.000338	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	4.89e-05	0.000336	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	4.88e-05	0.000336	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—OPRM1—nicotine dependence	4.81e-05	0.000331	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.8e-05	0.00033	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.78e-05	0.000329	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.74e-05	0.000326	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—WASF2—nicotine dependence	4.74e-05	0.000326	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.65e-05	0.00032	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.61e-05	0.000317	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.6e-05	0.000317	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	4.56e-05	0.000314	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.54e-05	0.000312	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	4.46e-05	0.000307	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.39e-05	0.000302	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.36e-05	0.0003	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.34e-05	0.000298	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—WASF2—nicotine dependence	4.32e-05	0.000297	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—WASF2—nicotine dependence	4.22e-05	0.00029	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.22e-05	0.00029	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.15e-05	0.000285	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	4.14e-05	0.000285	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—WASF1—nicotine dependence	4.14e-05	0.000285	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.13e-05	0.000284	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.11e-05	0.000282	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.09e-05	0.000281	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	4.06e-05	0.000279	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.06e-05	0.000279	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—WASF1—nicotine dependence	4.05e-05	0.000278	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4e-05	0.000275	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	3.96e-05	0.000272	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	3.94e-05	0.000271	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	3.83e-05	0.000263	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.78e-05	0.00026	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.77e-05	0.000259	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	3.76e-05	0.000259	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	3.73e-05	0.000256	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.69e-05	0.000254	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	3.64e-05	0.000251	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.62e-05	0.000249	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.57e-05	0.000245	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.56e-05	0.000245	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.56e-05	0.000245	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.55e-05	0.000244	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.53e-05	0.000243	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.49e-05	0.00024	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD2—nicotine dependence	3.48e-05	0.000239	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.48e-05	0.000239	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.45e-05	0.000237	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.43e-05	0.000236	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.42e-05	0.000235	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.41e-05	0.000235	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.35e-05	0.00023	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.34e-05	0.000229	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.33e-05	0.000229	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	3.31e-05	0.000227	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.24e-05	0.000223	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.18e-05	0.000218	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.13e-05	0.000215	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.11e-05	0.000214	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.08e-05	0.000212	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	3.07e-05	0.000211	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.01e-05	0.000207	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD2—nicotine dependence	2.96e-05	0.000203	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	2.83e-05	0.000194	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.8e-05	0.000193	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD2—nicotine dependence	2.69e-05	0.000185	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD2—nicotine dependence	2.64e-05	0.000181	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.58e-05	0.000177	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.56e-05	0.000176	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.49e-05	0.000171	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.23e-05	0.000153	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.22e-05	0.000153	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.18e-05	0.00015	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.18e-05	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.03e-05	0.000139	CbGpPWpGaD
